Tapewire

Nasdaq · USD

IRMD

IRADIMED CORP

Export transactions ↓
Tapewire entity
4896
SEC CIK
0001325618
Parsed reports
427

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025020
Dec 2025015
Jan 2026012
Feb 202601
Mar 2026015
Apr 2026023
May 2026022
Jun 202606
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 26, 2019 Filed Dec 4, 2019 21:39 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 02:27 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001334 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,408

Underlying: Common Stock · 6,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 02:27 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $22.80 $136,800.00
Disclosure

SEC source: 0000898432-19-001334 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.75 to $22.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 02:27 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001334 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001338 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,568

Underlying: Common Stock · 6,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $22.80 $136,800.00
Disclosure

SEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.75 to $22.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2019 Filed Dec 4, 2019 21:39 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001338 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 22, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 22, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.25 $139,500.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 22, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 1,840 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,568

Underlying: Common Stock · 1,840 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 4,160 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,160 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.25 $139,500.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 22, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 21, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 21, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.28 $139,680.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.20 to $23.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 21, 2019 Filed Nov 22, 2019 22:25 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001329 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.28 $139,680.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.20 to $23.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 21, 2019 Filed Dec 4, 2019 21:36 UTC Amendment
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001337 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 20, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 20, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.42 $140,520.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $23.40 to $23.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 20, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 20, 2019 Filed Nov 22, 2019 22:10 UTC SaleCommon Stock 5,288 $23.40 $123,739.20
Disclosure

SEC source: 0000898432-19-001328 · form4.xml · nonDerivative · entry 1

VUOTO ANTHONY · CIK 0001222060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,029

F1 · price: This transaction was executed in multiple trades at prices ranging from $23.255 to $23.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.05 $138,300.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $22.86 $137,160.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.80 to $23.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:15 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001323 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 15, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 15, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.02 $138,120.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 15, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.29 $139,740.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.07 to $23.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 14, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 13, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,160

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 13, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.68 $142,080.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.37 to $23.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 13, 2019 Filed Nov 15, 2019 22:44 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001311 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 12, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 11,300 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,160

Underlying: Common Stock · 11,300 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 12, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 11,300 $23.98 $270,974.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $23.60 to $24.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 12, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 11,300 $0.93 $10,509.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,668

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 11, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,460

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 11, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.02 $138,120.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 11, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 08, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,460

Underlying: Common Stock · 6,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 08, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 6,000 $23.06 $138,360.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.81 to $23.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2019 Filed Nov 12, 2019 22:18 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
GrantCommon Stock 6,000 $0.93 $5,580.00
Disclosure

SEC source: 0000898432-19-001303 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

Read SEC document
November 05, 2019 Filed Nov 6, 2019 23:47 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
Exercise / conversionStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $0.93 $0.00
Disclosure

SEC source: 0000898432-19-001298 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,460

Underlying: Common Stock · 4,000 shares

Expires 2021-12-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Read SEC document
November 05, 2019 Filed Nov 6, 2019 23:47 UTC
JOHNSON BRENTExec. VP of WW Sales and Mktg
SaleCommon Stock 4,000 $24.10 $96,400.00
Disclosure

SEC source: 0000898432-19-001298 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.85 to $24.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.